In this study, we systematically characterized POLD1 in ccRCC, revealing its expression profile, diagnostic and prognostic significance, somatic mutation difference, potential functions, immune infiltration, anticancer drug sensitivity prediction, and its association with the infiltration levels of immune cells. This evidence concerns the gene POLD1 and nonpapillary renal cell carcinoma.